Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Journal of Breast Cancer|December 30, 2017
Ectopic Male Breast Cancer in the Perineum: A Case ReportHye-Joung Eom, Beom Seok Ko, In Hye Song, et al.Acta Radiologica (Stockholm, Sweden : 1987)|August 3, 2017
Comparison of variability in breast density assessment by BI-RADS category according to the level of experienceHye-Joung Eom, Joo Hee Cha, Ji-Won Kang, et al.Acta Radiologica (Stockholm, Sweden : 1987)|June 3, 2024
Mammographic density assessment: comparison of radiologists, automated volumetric measurement, and artificial intelligence-based computer-assisted diagnosisHye Joung Eom, Joo Hee Cha, Woo Jung Choi, et al.AJR. American Journal of Roentgenology|March 29, 2017
Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerHye-Joung Eom, Joo Hee Cha, Woo Jung Choi, et al.Radiology|September 2, 2025
Node Reporting and Data System Evaluation of Axillary Nodes in Invasive Ductal and Lobular CarcinomaHee Jeong Kim, Eun Young Chae, Hye Joung Eom, et al.Radiology|April 29, 2025
Impact of Preoperative MRI on Survival Outcomes in Patients with HER2-positive and Hormone Receptor-negative Breast CancerHee Jeong Kim, Woo Jung Choi, Hye Joung Eom, et al.European Radiology|August 21, 2025
Combined use of two artificial intelligence-based algorithms for mammography triaging: a retrospective simulation studyHee Jeong Kim, Hak Hee Kim, Hye Joung Eom, et al.European Radiology|April 2, 2026
Long-term prognostic implications of AI-detected versus AI-undetected breast cancers on mammography: a propensity score-matched analysisHee Jeong Kim, Eun Young Chae, Hye Joung Eom, et al.European Radiology|June 24, 2025
Comparison of diffusion-weighted and contrast-enhanced MRI for monitoring response to neoadjuvant therapy in breast cancerHye Joung Eom, Hak Hee Kim, Hee Jeong Kim, et al.European Journal of Radiology|July 31, 2025
Background parenchymal enhancement as a predictor of invasive disease-free survival in hormone receptor-positive, HER2-negative breast cancerSu Min Cho, Hye Joung Eom, Hee Jeong Kim, et al.Pageof 3